Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 175   

Articles published

GSK 1,423.00 0.00 (0.00%)
price chart
GlaxoSmithKline plc Falls On Drop In Profits And Turnover
The share price of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is currently down over 3% following publication of a results announcement for the second quarter and interim management report for the half-year.
GlaxoSmithKline plc trims 2014 forecast  ValueWalk
GSK share price plunges as drugmaker slashes FY earnings forecast  iNVEZZ
Related articles »  
The Buy Case For GlaxoSmithKline plc Is Getting Stronger Every Day
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is looking more and more attractive as an investment every day. Indeed, as the company's share price continues to decline, following the release of its downbeat half-year results, Glaxo is getting cheaper and ...
Eyes Down For GlaxoSmithKline plc Results
gsk GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been overshadowed a bit of late by takeover attempts at rival AstraZeneca, and its share price has lagged a little - it's been see-sawing all year and is down around 8% over the past 12 months, ...
Related articles »  
The Rising Pound Will Hit GlaxoSmithKline plc, BHP Billiton plc, ARM Holdings ...
A strong currency is a sign of global punching power, but it can leave investors on the ropes. Sterling's resurgence has dealt a few body blows to the FTSE 100, whose constituents generate more than three-quarters of their earnings overseas.
Related articles »  
Is Hikma Pharmaceuticals Plc A Better Buy Than GlaxoSmithKline plc Or Shire ...
shire It's been a great first half of 2014 for investors in Hikma (LSE: HIK), with the pharmaceutical company seeing its share price rise by 47%, while the FTSE 100 is up just 1.5%.
After Another Shire PLC Bid, Could AstraZeneca plc Or GlaxoSmithKline plc Be ...
shire With Abbvie's �53.20 per share offer receiving a 'thumbs up' from the board of Shire (LSE: SHP), it means that shares in the healthcare stock have risen by 75% during the course of 2014.
Related articles »  
Zacks Reiterates �Underperform� Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc (ADR) logo GlaxoSmithKline plc (NYSE:GSK)'s stock had its �underperform� rating reiterated by Zacks in a report released on Friday.
GSK Has Option To Separate Its Consumer Healthcare Business: FT  NASDAQ
Glaxo CEO floats possible consumer spin-off: report  MarketWatch
Related articles »  
3 Things That Say GlaxoSmithKline plc Is A Buy
Well, having the company in the Fool's Beginners' Portfolio, reckon I can say it's cheap! Here are three things that would make me add GlaxoSmithKline if it wasn't already there: 1. Fundamentals. Quality companies are often rated on higher-than-average ...
Neil Woodford Still Loves Astrazeneca plc And GlaxoSmithKline plc
AstraZeneca Loyalty is a wonderful thing, and Neil Woodford has bags of it. He has just announced the top 10 holdings in his new CF Woodford Equity Income fund, and the only surprise is how few surprises there are.
Ex-Invesco star Woodford's start-up bets on tobacco, drug firms  Reuters UK
Woodford's Cautious Stance See Glaxo, BAT Top 10 Holdings  Businessweek
Related articles »  
GlaxoSmithKline plc (ADR) (GSK) Announces Quarterly Dividend of $0.65
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) declared a quarterly dividend on Thursday, July 24th, American Banking News.